Cognex
Active Ingredient(s): TacrineFDA Approved: * September 9, 1993
Pharm Company: * FIRST HORIZON
Category: Alzheimers / Dementia
Tacrine is a centrally acting acetylcholinesterase inhibitor and indirect cholinergic agonist (parasympathomimetic). It was the first centrally acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex. Tacrine was first synthesised by Adrien Albert at the University of Sydney in 1949. It also acts as a histamine N-methyltransferase inhibitor.[1] Contents 1 Clinical use 2 Adverse Effects 2.1 Overdose 3 ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.5 Discussions
Popular Topics
Patient Have A Swelling In Feet And Using Medicine Cognex Plus
MY GRAND MOTHER HAS HAVING A DEFECT OR SWELLING FROM 7 DAYS & HE NOT ABLE TO WALK AS USALLY AND USING MEDICINE COGNE...